Author

K. Ji

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

B. Zhao· 1 shared C. Dong· 1 shared C.-i. Hwang· 1 shared D. Kawauchi· 1 shared E. Lee· 1 shared I. Hasegawa· 1 shared J. Pena· 1 shared K. Ichijo· 1 shared

Activity by Year

2017-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

B. Zhao

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Meis1 isoform diversity orchestrates neural progenitor differentiation by regulating ATOH1 degradation at distinct subcellular compartments

T. Owa, T. Adachi, R. Shiraishi, K. Ichijo, K. Ji, M. Mizuno, K. Suyama, K. Nishitani, I. Hasegawa, M. Sone, D. Kawauchi, T. Nishioka, S. Taya, Y. Suzuki, K. Kaibuchi, , M. Hoshino

The paper identifies functionally antagonistic Meis1 isoforms that regulate ATOH1 degradation through distinct subcellular localization and E3 ligase interactions, affecting neural progenitor differentiation.

PLOS Biology · Jul 13, 2026Peer-reviewedCell Biology

A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer

E. Lee, S. Archasappawat, K. Ji, J. Pena, V. Fernandez-Vega, R. Gangaraju, N. S. Beesabathuni, M. Kim, Q. Tian, P. Shah, L. Scampavia, T. Spicer, C.-i. Hwang

This study identifies BET inhibition as a potential therapy for BRCA2-deficient pancreatic cancer by showing it enhances autophagy-dependent cell death in these cells.

bioRxiv · May 30, 2023 · PreprintCancer Biology

FGF21 regulates melanogenesis in alpaca melanocytes via ERK1/2-Mediated MITF downregulation

R. Wang, T. Chen, B. Zhao, R. Fan, K. Ji, X. Yu, X. Wang, C. Dong

This study shows FGF21 reduces melanogenesis in alpaca melanocytes by activating ERK1/2 and downregulating MITF, leading to decreased melanin production.

bioRxiv · Jun 7, 2017Cell Biology